Mark G. Jones - Concepedia

Author

Mark G. Jones

University of Southampton ORCID

Also Known As

B Guillen Guio, H Jones, H. Jones, I Jones, I. Jones, J Skeemer, John R Hurst, Jones, Mark, Jones, Mark G., L S Howard

182

Publications

7.8K

Citations

H-Index

101

Concepts

All Affiliations

University of Southampton NIHR Southampton Biomedical Research Centre University Hospital Southampton NHS Foundation Trust University College London Imperial College London

About

Mark G. Jones is an author at University of Southampton specializing in medicine, covid-19, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	1.4K
2	Public Health	4	4	196
3	Engineering	3	3	248
4	Health Sciences	3	3	53
5	Natural Sciences	1	1	16

Mark G. Jones

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study Xiaojun Wu, Xiaofan Liu, Yilu Zhou, The Lancet Respiratory Medicine Respiratory DiseasesMedicineCovid-19 PandemicRespiratory InfectionOutcomes Research	2021	706
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison, American Journal of Respiratory and Critical Care Medicine	2020	228
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey Julie Morisset, Kerri A. Johannson, Kirk D. Jones, American Journal of Respiratory and Critical Care Medicine	2017	227
Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis Charlotte Hill, Juanjuan Li, Dian Liu, Cell Death and Disease	2019	169
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis Mark G. Jones, Orestis G. Andriotis, James Roberts, eLife Tissue EngineeringEngineeringInflammatory Lung DiseaseLung InflammationTissue Stiffness	2018	162
Paracrine signalling during ZEB1-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in lung fibrosis Liudi Yao, Franco Conforti, Charlotte Hill, Cell Death and Differentiation	2018	145
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study Iain Stewart, Joseph Jacob, Peter M. George, American Journal of Respiratory and Critical Care Medicine	2022	139
Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Robert O. Bonow, Douglas R. Rosing, B J Maron, Circulation Heart FailureCardiothoracic SurgeryCardiovascular DiseaseCardiac MechanicLeft Ventricular Dysfunction	1984	132
Epithelial-Mesenchymal Transition Contributes to Pulmonary Fibrosis via Aberrant Epithelial/Fibroblastic Cross-Talk Charlotte Hill, Mark G. Jones, Donna E. Davies, Journal of Lung Health and Diseases	2019	130

Page 1